Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.55
-0.15 (-0.80%)
Jul 11, 2025, 1:54 PM CST
-8.40%
Market Cap 1.36B
Revenue (ttm) 482.75M
Net Income (ttm) -223.10M
Shares Out 72.45M
EPS (ttm) -3.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,287
Average Volume 87,060
Open 18.65
Previous Close 18.70
Day's Range 18.25 - 18.65
52-Week Range 14.30 - 22.70
Beta 0.01
RSI 54.13
Earnings Date Aug 8, 2025

About Genomics BioSci & Tech.

Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; reproductive health and cancer testing services; and contract development and manufacturing services. Genomics BioSci & Tech. Co.,Ltd. was founded in 2001 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4195
Full Company Profile

Financial Performance

In 2024, Genomics BioSci & Tech.'s revenue was 482.75 million, an increase of 21.86% compared to the previous year's 396.14 million. Losses were -223.10 million, 32.7% more than in 2023.

Financial Statements

News

There is no news available yet.